A groundbreaking clinical trial has launched in Japan, offering a novel viral therapy that targets esophageal cancer cells. Early results suggest promising efficacy, marking the first such intervention worldwide.
Also Read
- Ed Martin Exits Justice Department Following Contentious Tenure
- Nigeria Investigates Fraudulent Government Agency Unveiled in Recent Probe
- i-80 Gold CEO Richard Scott Young Buys 1 Million Shares. What Does This Mean for Investors?
- TikTok Reaches $400 Million Settlement Over U.S. Children’s Privacy Violations